Carfilzomib‐Induced Thrombotic Microangiopathy—Two Case Reports

ABSTRACTBackgroundThrombotic microangiopathy (TMA) is a pathological syndrome characterized by a combination of three key features: microangiopathic hemolytic anemia (MAHA), thrombocytopenia, and organ damage, primarily affecting the kidneys. There are several drugs known to have a definite or proba...

Full description

Bibliographic Details
Published in:	Cancer Reports
Main Authors:	Irene Attucci, Sofia Pilerci, Maria Messeri, Ludovica Pengue, Giulia Tomasino, Leonardo Caroti, Alessandro M. Vannucchi, Elisabetta Antonioli
Format:	Article
Language:	English
Published:	Wiley 2024-10-01
Subjects:	carfilzomib proteasome inhibitors renal impairment thrombotic microangiopathy
Online Access:	https://doi.org/10.1002/cnr2.2163

Similar Items

Effective Management of Carfilzomib-Induced Thrombotic Microangiopathy in Multiple Myeloma Using Eculizumab
by: Jennifer Kim, et al.
Published: (2025-06-01)

Delayed Onset of Thrombotic Microangiopathy (TMA) upon Prolonged Carfilzomib Therapy in Multiple Myeloma: A Case Report and Comprehensive Review
by: Andrea Ceglédi, et al.
Published: (2024-12-01)

Microangiopathy in multiple myeloma: a case of carfilzomib-induced secondary thrombotic microangiopathy successfully treated with plasma exchange and complement inhibition
by: Lorenzo Catanese, et al.
Published: (2023-06-01)

Drug review: Carfilzomib
by: Prasanth Ganesan
Published: (2019-01-01)

Thrombotic microangiopathy associated with Valproic acid toxicity
by: Sean A. Hebert, et al.
Published: (2017-08-01)

Lupus nephritis and thrombotic microangiopathy: A review
by: Larisa A. Bobrova, et al.
Published: (2024-01-01)

Rare Case of Congenital Thrombotic Thrombocytopenic Purpura Presenting as Posttransplant Thrombotic Microangiopathy
by: Akila Viswanathan, et al.
Published: (2024-12-01)

Thrombotic microangiopathy associated with lenvatinib therapy
by: Macarena Contreras Angulo, et al.
Published: (2023-04-01)

Eculizumab for bevacizumab induced thrombotic microangiopathy: A case report
by: Mihriban İnözü, et al.
Published: (2022-12-01)

Posttransplant thrombotic microangiopathy: Unraveling a mystery
by: Mohammed Fahad Khan, et al.
Published: (2024-01-01)

Posttransplant thrombotic microangiopathy: Unraveling a mystery
by: Mohammed Fahad Khan, et al.
Published: (2024-01-01)

Three shades of black - secondary thrombotic microangiopathy
by: Rhituparna Das, et al.
Published: (2022-01-01)

COVID‐19‐induced thrombotic microangiopathy: A great mimicker of thrombotic thrombocytopenic purpura (TTP)
by: Brian Warnecke, et al.
Published: (2023-01-01)

Thrombotic microangiopathy after kidney transplantion
by: Mohammad Sami Tahseen, et al.
Published: (2023-12-01)

An Update in Drug-Induced Thrombotic Microangiopathy
by: Thomas Chatzikonstantinou, et al.
Published: (2020-05-01)

Near-fatal cocaine intoxication in an infant with thrombotic microangiopathy associated with multiple organ failure
by: Alejandro Donoso Fuentes, et al.
Published: (2023-08-01)

Diagnostic Testing for Differential Diagnosis in Thrombotic Microangiopathies
by: Gina Zini, et al.
Published: (2019-11-01)

THROMBOTIC MICROANGIOPATHY IN THE PATHOGENESIS OF OBSTETRIC COMPLICATIONS
by: S. V. Akinshina, et al.
Published: (2016-06-01)

Thrombotic Microangiopathy in Renal Transplant Recipients
by: S. Murugesh Anand, et al.
Published: (2024-06-01)

Carfilzomib-Induced Thrombotic Microangiopathy Treated with Eculizumab: A Case Report and Rapid Literature Review
by: Federica Pallotti, et al.
Published: (2022-12-01)

Fruquintinib-induced renal-limited thrombotic microangiopathy: a case report
by: Ruiping Zhao, et al.
Published: (2024-05-01)

Transplant-associated thrombotic microangiopathy
by: Tomasz Jarmoliński
Published: (2021-09-01)

Cancer-related thrombotic microangiopathies: case report and narrative review
by: Micaela La Regina, et al.
Published: (2018-12-01)

Drug Induced Thrombotic Microangiopathy with Certolizumab Pegol
by: Mehmet Baysal, et al.
Published: (2018-09-01)

Thrombotic microangiopathy secondary to Capnocytophaga canimorsus bacteremia
by: Enrique Chicote-Álvarez, et al.
Published: (2023-11-01)

COVID-19 and thrombotic microangiopathy
by: E. V. Sluhanchuk, et al.
Published: (2022-01-01)

Fibrillary Glomerulonephritis with Crescentic and Necrotizing Glomerulonephritis and Concurrent Thrombotic Microangiopathy
by: Calvin Tsui, et al.
Published: (2018-08-01)

Thrombotic Microangiopathy in Interferon‐beta‐Treated Multiple Sclerosis Patient
by: Masoud Mohammad Malekzadeh, et al.
Published: (2020-06-01)

Thrombotic microangiopathy resulting from neglected blood pressure control
by: Jeong Sang Ku, et al.
Published: (2014-06-01)

Secondary thrombotic microangiopathy and eculizumab: A reasonable therapeutic option
by: Elena Román, et al.
Published: (2017-09-01)

Disseminated cerebral thrombotic microangiopathy in a patient with adult's Still disease
by: Renan B. Domingues, et al.
Published: (2003-06-01)

Thrombotic Microangiopathy Revealing Bone Metastases from an Ethmoid Sinus Carcinoma
by: Mony Chenda Morisse, et al.
Published: (2016-08-01)

Thrombotic microangiopathies: An illustrated review
by: Mouhamed Yazan Abou‐Ismail, et al.
Published: (2022-03-01)

Lombardy diagnostic and therapeutic network of thrombotic microangiopathy
by: I. Mancini, et al.
Published: (2022-06-01)

Carfilzomib, lenalidomide, and dexamethasone in relapsed refractory multiple myeloma: a prospective real-life experience of the Regional Tuscan Myeloma Network
by: Elisabetta Antonioli, et al.
Published: (2023-04-01)

Characteristics and management of thrombotic microangiopathy in kidney transplantation
by: Wonyong Cho, et al.
Published: (2023-03-01)

Narsoplimab for severe transplant-associated thrombotic microangiopathy
by: Ambreen Pandrowala, et al.
Published: (2023-03-01)

Thrombotic microangiopathies during pregnancy: differential diagnosis. A clinical case report
by: Mónica I. Prieto-Baca, et al.
Published: (2025-10-01)

Association of thrombotic microangiopathy with interferon therapy for hepatitis B: a case report
by: Shan Wei, et al.
Published: (2024-07-01)

A case of gemcitabine-induced thrombotic microangiopathy in a urothelial tumor patient with a single kidney
by: Hyunjin Ryu, et al.
Published: (2015-12-01)